The diagnostic power of testing progesterone urine metabolites

$25.00

Amy Beckley, Phd., CEO of MFB Fertility, presents on the use and technique of urinary progesterone metabolite measurement and applications of current assays. work during the North American Conference for RRM held on July 22, 2020.  Learn how a new urine PDG test (Progesterone Ovulation Test “Proov,” https://proovtest.com) is being utilized to confirm ovulation status and the different conditions this can be used to support.

Description

Conference Keynote Session: The diagnostic power of testing progesterone urine metabolites 

Presented by: Amy Beckley, PhD, MBA. CEO of MFB Fertility

Amy Beckley has an MBA and a PhD in Pharmacology. She has studied hormone signaling for over 20 years. Amy is the Founder and CEO of MFB Fertility, Inc. Her team commercialized the first and only FDA-cleared home urine progesterone metabolite (PDG) testing kit. Proov Tests have helped over 20,000 women confirm ovulation from the comfort of their home.

Learning objectives:

  1. Discuss the use and technique of urinary progesterone metabolite measurement
  2. Review the historical and current urinary progesterone metabolite assays.
  3. Learn the applications of current assays.

After purchase you will receive an email granting access to this session.  If you have any difficulties please send us a message.

Estimated Time to Complete Activity:  60 minutes

Faculty Disclosure: Amy Beckley is an employee/CEO of MFB Fertility, Inc. (Proov Test).

This session was presented live on July 22, 2020 at the North American Regional Conference for RRM.  Access to all recordings from the conference are available for purchase at this link.

 

1.0 CME/CPD credit available with completion of the post-activity evaluation until Sept. 1 2020.  After which a certificate of completion will be issued with completion of the post-activity evaluation.